Mumbai: Piramal Pharma Limited has approved the exercise of its call option to acquire the remaining 26% equity stake in Yapan Bio Private Limited, a subsidiary of the company, taking its shareholding from the existing 74% to 100%.
In a disclosure, Piramal Pharma informed that the Administrative Committee of its Board of Directors, acting under the authority delegated by the Board, had approved the exercise of the call option to acquire the balance stake in Yapan Bio from its existing shareholders.
Following the exercise of the call option, the company is currently engaged in discussions with Yapan Bio's existing shareholders regarding various matters necessary for completing the proposed transaction.
However, the final terms of the acquisition, including the acquisition consideration and the effective date of the transfer of shares, are yet to be finalised. The company stated that it would make appropriate disclosures, including the details required under Regulation 30 of the SEBI Listing Regulations, upon execution of the definitive documentation and completion of the proposed transaction.
Yapan Bio Private Limited is a Contract Development and Manufacturing Organization (CDMO) specialising in process development, characterisation and Phase I/II Good Manufacturing Practice (GMP) manufacturing services for vaccines and biologics.
Upon completion of the proposed acquisition, Piramal Pharma's shareholding in Yapan Bio is expected to increase from the current 74% to 100%, making Yapan Bio a wholly owned subsidiary of Piramal Pharma Limited.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.